Stay updated with breaking news from Drma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) was the recipient of a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 14,400 shares, a decline of 10.0% from the July 31st total of 16,000 shares. Based on an average trading volume of 164,800 shares, […] ....
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) shares shot up 2.7% during mid-day trading on Monday . The stock traded as high as $1.16 and last traded at $1.16. 10,027 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 1,352,323 shares. The stock had previously closed at […] ....
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report)’s share price was down 2% on Friday . The company traded as low as $1.49 and last traded at $1.49. Approximately 53,953 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 1,501,428 shares. The stock had previously closed at $1.52. […] ....
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Free Report) saw a significant increase in short interest in June. As of June 15th, there was short interest totalling 70,300 shares, an increase of 221.0% from the May 31st total of 21,900 shares. Based on an average daily volume of 2,940,000 shares, the days-to-cover ratio is currently 0.0 days. […] ....
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 63,100 shares, an increase of 248.6% from the April 15th total of 18,100 shares. Approximately 0.7% of the company’s shares are short sold. Based […] ....